JY
GLMD icon

Jeff Yass’s Galmed Pharmaceuticals GLMD Stock Holding History

Jeff Yass’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-121
Closed -$3.33K – 12354
2024
Q2 		$3.33K Buy
+121
New +$4.25K ﹤0.01% 11834
2023
Q3 		– Sell
-267
Closed -$74.5K – 12350
2023
Q2 		$74.5K Buy
+267
New +$115K ﹤0.01% 11142
2023
Q1 		– Sell
-7
Closed -$5K – 12908
2022
Q4 		$5K Hold
7
– – ﹤0.01% 12046
2022
Q3 		$3K Hold
7
– – ﹤0.01% 12920
2022
Q2 		$7K Buy
+7
New +$9.28K ﹤0.01% 12569
2022
Q1 		– Sell
-93
Closed -$211K – 13362
2021
Q4 		$244K Buy
93
+62
+200% +$224K ﹤0.01% 11006
2021
Q3 		$124K Buy
31
+15
+94% +$62.9K ﹤0.01% 11925
2021
Q2 		$72K Buy
16
+7
+78% +$30.4K ﹤0.01% 12211
2021
Q1 		$47K Buy
9
+2
+29% +$11.1K ﹤0.01% 12046
2020
Q4 		$33K Buy
+7
New +$35K ﹤0.01% 10827
2020
Q1 		– Sell
-9
Closed -$74K – 10474
2019
Q4 		$74K Sell
9
-1
-10% -$6.87K ﹤0.01% 9238
2019
Q3 		$72K Sell
10
-1
-9% -$8.03K ﹤0.01% 9683
2019
Q2 		$121K Buy
11
+3
+38% +$31K ﹤0.01% 9513
2019
Q1 		$99K Hold
8
– – ﹤0.01% 8252
2018
Q4 		$79K Buy
+8
New +$112K ﹤0.01% 8318
2017
Q1 		– Sell
-13
Closed -$66K – 9293
2016
Q4 		$66K Buy
+13
New +$68.7K ﹤0.01% 9215

Other funds holding GLMD

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

Jeff Yass's GLMD Position: Q3 2024 in Review

Jeff Yass sold out of Galmed Pharmaceuticals (GLMD) in Q3 2024, closing a stake of 121 shares — an estimated $3.33K sold.

Jeff Yass first reported a position in GLMD in Q4 2016 and held it in 16 quarters. The position peaked at $244K in Q4 2021. 7 funds tracked by Wall St. Rank hold GLMD as of Q3 2024.

  • Jeff Yass reported no remaining Galmed Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 121 Galmed Pharmaceuticals shares in Q3 2024, an estimated $3.33K.
  • Jeff Yass first reported a position in Galmed Pharmaceuticals in Q4 2016 and held it in 16 quarters.
  • Jeff Yass's Galmed Pharmaceuticals position peaked at $244K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.